Open AccessEfficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation
Author(s) -
Tadeusz Wojciech Łapiński,
Robert Flisiak,
Jerzy Jaroszewicz,
Małgorzata Michalewicz,
Oksana Kowalczuk
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i3.400
Subject(s) - lamivudine , medicine , dialysis , gastroenterology , hbeag , hemodialysis , kidney transplantation , transplantation , creatinine , renal function , kidney disease , kidney , hepatitis b , hbsag , hepatitis b virus , immunology , virus
To analyze the effectiveness and safety of lamivudine treatment in patients with chronic HBV infection undergoing hemodialysis or after kidney transplantation, and to study the frequency of tyrosine-methionine-aspartate-aspartate (YMDD) mutation occurrence after lamivudine treatment.